ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Antoine To Leave As RP Director, Will Join ROB

November 2, 1990

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

January 8, 1999

In Brief: Gigliotti Named Greenwald Special Assistant; Coltman To Get ACCC Clinical Research Award

August 26, 1988

NCI Continues Making Improvements In Contract Management

May 22, 1981

OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent

April 15, 1983